Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland

Podobne zapisy

• Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland
  od: Maria Trottmann, i wsp.
  Wydane: (2024-10-01)
• Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: results of a pragmatic consensus process
  od: Eva Blozik, i wsp.
  Wydane: (2018-09-01)
• Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland
  od: Radoslaw Panczak, i wsp.
  Wydane: (2018-03-01)
• Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: update of the SQUIPRICA working group
  od: Eva Blozik, i wsp.
  Wydane: (2022-05-01)
• Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data
  od: Caroline Arber, i wsp.
  Wydane: (2024-10-01)